Evidence-Based Robot-Assistant in Neurorehabilitation
Launched by UNIVERSITY MEDICINE GREIFSWALD · Dec 7, 2021
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment called E-BRAiN, which uses a robot to help people recover from the effects of a stroke. The study aims to find out how well this robot-assistant works, how safe it is, and whether patients and their families find it acceptable. If you or a loved one has had a stroke and are experiencing issues like weakness in your arm or difficulty with visual perception, you might be eligible to participate in this study.
To qualify, participants need to be at least 18 years old and have had a stroke, which can be due to different types of brain damage. They should also have some arm weakness or challenges with seeing things in their environment. Participants will receive the E-BRAiN treatment and will be monitored throughout the study. It’s important to know that certain conditions, like being pregnant or having other serious health issues, may prevent someone from joining. This trial is currently recruiting participants, and it could be an opportunity to explore a new way to aid recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age at study entry ≥ 18 years
- • Stroke (ischemic stroke, non-traumatic intracerebral haemorrhage, subarachnoidal haemorrhage)
- • Incomplete arm paresis (Motricity Index, arm score \>1 \[Min\] and \< 100 \[Max\]) or
- • Visuospatial neglect (clinical signs and NET subtest "star cancellation" score \< 50)
- • Candidate able to consent and provides informed consent or
- • legal representative provides informed consent
- Exclusion Criteria:
- • Pregnant or breast feeding
- • Obliged to live in an institution by law or public authority
- • With case presentation arm paresis: another condition that causes arm paresis is present
- • With case presentation visuospatial neglect: another condition that causes a relevant visual-perceptual deficit that cannot be compensated is present; exception: homonymous visual field deficits are not an exclusion criterion
About University Medicine Greifswald
University Medicine Greifswald is a prominent academic medical center located in Greifswald, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a clinical trial sponsor, it fosters a collaborative environment that integrates cutting-edge scientific inquiry with patient care, focusing on a wide range of medical disciplines. The institution is committed to enhancing patient outcomes by conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory requirements. With a strong emphasis on interdisciplinary collaboration, University Medicine Greifswald aims to contribute significantly to the development of new therapies and medical advancements, ultimately improving healthcare delivery and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Greifswald, , Germany
Greifswald, , Germany
Patients applied
Trial Officials
Thomas Platz, Prof.Dr.med.
Principal Investigator
Head, Neurorehabilitation Research Group
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials